Nonclercq D, Toubeau G, Tulkens P, Heuson-Stiennon J A, Laurent G
Laboratoire d'Histologie, Faculté de Médecine, Université de Mons-Hainaut, Belgium.
Virchows Arch B Cell Pathol Incl Mol Pathol. 1990;59(3):143-58. doi: 10.1007/BF02899399.
The administration of anticancer platinum derivatives such as cisplatin, or aminoglycoside antibiotics is frequently associated with tubular necrosis which can eventually lead to acute renal failure. Previously, we have shown that renal tissue injury induced by these drugs elicits a process of tissue repair involving the stimulation of cell proliferation. The present study was undertaken to examine the morphological alterations and the proliferative response resulting from tobramycin administration to animals previously challenged with the platinum derivatives cisplatin and carboplatin. Female Sprague-Dawley rats were treated i.p. with cisplatin (8 mg/kg delivered in four daily injections) or carboplatin (40 mg/kg given in one injection) and sacrificed 21 or 60 days after drug administration. Tobramycin was administered i.p. twice a day at a daily dose of 10 mg/kg over the ten days preceding sacrifice. At 1 h before sacrifice, each animal received i.p. 200 microCi of [3H] thymidine for the measurement of DNA synthesis and cell proliferation (determined by histoautoradiography). Successive treatments with cisplatin and tobramycin appeared to produce an increase in the severity of histopathological alterations such as tubular necrosis and cystic degeneration. Moreover, cisplatin pretreatment dramatically increased the severity of tobramycin-induced lysosomal phospholipidosis. Histopathological alterations were followed by an important proliferative response partly associated with tubular regeneration but also due to fibroblastic proliferation which led to peritubular fibrosis. Surprisingly, the additive effect of cisplatin and tobramycin on renal injury became particularly striking with increasing time intervals between treatments. In contrast, successive treatments with carboplatin and tobramycin did not cause significative changes of the degree of renal injury, compared with either drug given alone.(ABSTRACT TRUNCATED AT 250 WORDS)
给予抗癌铂类衍生物(如顺铂)或氨基糖苷类抗生素常常会引发肾小管坏死,最终可能导致急性肾衰竭。此前,我们已经表明,这些药物诱导的肾组织损伤会引发一个涉及刺激细胞增殖的组织修复过程。本研究旨在检查给予先前用铂类衍生物顺铂和卡铂攻击过的动物妥布霉素后所产生的形态学改变和增殖反应。对雌性斯普拉格 - 道利大鼠腹腔注射顺铂(每日分四次注射,每次8 mg/kg)或卡铂(一次注射40 mg/kg),并在给药后21天或60天处死。在处死前的十天里,每天两次腹腔注射妥布霉素,每日剂量为10 mg/kg。在处死前1小时,每只动物腹腔注射200微居里的[3H]胸腺嘧啶核苷,用于测量DNA合成和细胞增殖(通过组织放射自显影术确定)。顺铂和妥布霉素的连续治疗似乎会使组织病理学改变(如肾小管坏死和囊性变性)的严重程度增加。此外,顺铂预处理显著增加了妥布霉素诱导的溶酶体磷脂沉积症的严重程度。组织病理学改变之后是重要的增殖反应,部分与肾小管再生有关,但也归因于成纤维细胞增殖,这导致了肾小管周围纤维化。令人惊讶的是,随着治疗间隔时间的增加,顺铂和妥布霉素对肾损伤的累加效应变得尤为显著。相比之下,与单独给予任何一种药物相比,卡铂和妥布霉素的连续治疗并未引起肾损伤程度的显著变化。(摘要截短于250字)